Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Long-term follow-up for multidrug-resistant tuberculosis.

Sonya S Shin¹, Jennifer J Furin, Felix Alcántara

¹Brigham and Women's Hospital, Boston, Massachusetts, USA.

Emerging Infectious Diseases

|May 18, 2006

Summary

Long-term follow-up of Peruvian patients shows multidrug-resistant tuberculosis (MDR-TB) treatment leads to sustained health and improved employment for most survivors. High cure rates indicate successful MDR-TB management strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Low Post-Treatment Recurrence After a Shortened All-oral Regimen for Pulmonary Rifampicin- or Multidrug-Resistant Tuberculosis in Individuals without Prior Second-Line Drug Exposure in Kazakhstan.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Same author

Comparison of three linezolid management strategies for peripheral neuropathy in multidrug- or rifampicin-resistant tuberculosis treatment: a target trial emulation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Same author

Interventions to reduce the impact of post-tuberculosis lung disease: a scoping review of the literature.

BMC pulmonary medicine·2026

Same author

endTB-Q trial: a caveat on confounding by baseline drug resistance - Authors' reply.

The Lancet. Respiratory medicine·2026

Same author

Comparison of three linezolid management strategies for peripheral neuropathy in multidrug- or rifampicin-resistant tuberculosis treatment: a target trial emulation.

medRxiv : the preprint server for health sciences·2026

Same author

When are uncontrolled trials in TB scientifically and ethically justified: Borrowing wisdom from early AIDS clinical trials.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Area of Science:

Public Health
Infectious Diseases
Tuberculosis Research

Background:

Multidrug-resistant tuberculosis (MDR-TB) poses a significant global health challenge.
Effective long-term management strategies for MDR-TB are crucial for patient recovery and public health.
Understanding the long-term outcomes of MDR-TB treatment is essential for improving patient care.

Purpose of the Study:

To evaluate the long-term health and socioeconomic outcomes of patients treated for MDR-TB in Peru.
To assess the sustained cure rates and relapse incidence following MDR-TB treatment.
To determine the impact of MDR-TB treatment on patient employment status.

Main Methods:

A retrospective follow-up study of patients treated for MDR-TB in Peru.

Related Experiment Videos

Median follow-up duration of 67 months for 86 patients declared cured.

Assessment of patient health status and employment rates before and after treatment.

Main Results:

97% of patients remained healthy with sustained cure after a median of 67 months.
Only 1 out of 86 cured patients experienced a relapse.
Significant increase in employment rates, from 34% before treatment to 71% post-treatment.

Conclusions:

MDR-TB treatment in Peru demonstrates favorable and sustained long-term outcomes.
Successful MDR-TB treatment contributes to significant improvements in patients' quality of life and economic participation.
The findings support the effectiveness of current MDR-TB treatment protocols in Peru.